Evidence map›Paper›PMID 30808965›Full record

ArticleScientific reports2019

Directed Differentiation of Human Pluripotent Stem Cells to Podocytes under Defined Conditions.

Tongcheng Qian, Shaenah E Hernday, Xiaoping Bao, William R Olson, Sarah E Panzer, Eric V Shusta, Sean P Palecek

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.Pflugers Archiv : European journal of physiology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Wnt signaling in kidney: the initiator or terminator?Journal of molecular medicine (Berlin, Germany) · 2020
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Tongcheng QianDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA.
Shaenah E HerndayDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA.
Xiaoping BaoDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA.
William R OlsonDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA.
Sarah E PanzerSchool of Medicine and Public Health, University of Wisconsin, Madison, WI, 53706, USA.
Eric V ShustaDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA. eshusta@wisc.edu.
Sean P PalecekDepartment of Chemical & Biological Engineering, University of Wisconsin, Madison, WI, 53706, USA. sppalecek@wisc.edu.
University of Wisconsin–Madison · US

Funding

RXRalpha and PPARdelta Signaling as Novel Regulators of the Blood-Brain BarrierR01NS083688 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SHUSTA, ERIC V · 2013 to 2017
$1.9M
Shear regulated differentiation of hPSCs to brain endothelial cellsR21NS085351 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2013 to 2014
$407k
NINDS NIH HHS R01 NS083688NINDS NIH HHS R21 NS085351
6 · The paper itself

Abstract

A major cause of chronic kidney disease (CKD) is glomerular disease, which can be attributed to a spectrum of podocyte disorders. Podocytes are non-proliferative, terminally differentiated cells. Thus, the limited supply of primary podocytes impedes CKD research. Differentiation of human pluripotent stem cells (hPSCs) into podocytes has the potential to produce podocytes for disease modeling, drug screening, and cell therapies. In the podocyte differentiation process described here, hPSCs are first induced to primitive streak-like cells by activating canonical Wnt signaling. Next, these cells progress to mesoderm precursors, proliferative nephron progenitors, and eventually become mature podocytes by culturing in a serum-free medium. Podocytes generated via this protocol adopt podocyte morphology, express canonical podocyte markers, and exhibit podocyte phenotypes, including albumin uptake and TGF-β1 triggered cell death. This study provides a simple, defined strategy to generate podocytes for in vitro modeling of podocyte development and disease or for cell therapies.

Indexed as

Cell DifferentiationCells, CulturedHumansMesodermNanog Homeobox ProteinOctamer Transcription Factor-3PhenotypePluripotent Stem CellsPodocytesPrimitive StreakWnt ProteinsNanog Homeobox ProteinOctamer Transcription Factor-3Wnt Proteins

Identifiers

PMID30808965
PMCPMC6391455
OpenAlexW2917322704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.